Clinical Trials Sponsored by Lone Forner

Total 2724 results

Dana-Farber Cancer Institute

Completed

Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain

Cancer

United States
Dana-Farber Cancer Institute

Completed

Intravenous Magnesium in Patients Receiving Cisplatin

Mesothelioma

United States
Dana-Farber Cancer Institute

Completed

Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy

Prostate Cancer

United States
Dana-Farber Cancer Institute

Completed

Cisplatin + RT for Triple Negative Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute

Completed

Pembrolizumab +/- Bevacizumab for Recurrent GBM

Glioblastoma

United States
Dana-Farber Cancer Institute

Terminated

The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids

Gynecologic Tumor

United States
Dana-Farber Cancer Institute

Completed

The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer Patients

Gastro Intestinal Cancer

United States
Dana-Farber Cancer Institute

Completed

Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GVHD

Chronic Versus Graft Host Disease

United States
Dana-Farber Cancer Institute

Completed

Ibrutinib (PCI-32765) in Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
Dana-Farber Cancer Institute

Completed

Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning

Prostate Cancer | Adenocarcinoma of the Prostate Stage I | Adenocarcinoma of the Prostate Stage II | Adenocarcinoma of the Prostate Stage III

United States
Dana-Farber Cancer Institute

Completed

BKM120 For Triple Negative Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute

Completed

Exercise and Metformin in Colorectal and Breast Cancer Survivors

Breast Cancer | Colorectal Cancer

United States
Dana-Farber Cancer Institute

Completed

Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
Dana-Farber Cancer Institute

Completed

Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant

Graft Versus Host Disease

United States
Armed Forces Hospital, Pakistan

Unknown

Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy (citicoline)

Hypoxic-Ischemic Encephalopathy

Pakistan
Dana-Farber Cancer Institute

Completed

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

Lymphoma | Leukemia | Myelodysplastic Syndrome

United States
Dana-Farber Cancer Institute

Terminated

Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

Multiple Myeloma | Thrombocytopenia

United States
Dana-Farber Cancer Institute

Completed

Cabozantinib for Metastatic Triple Negative BrCa

Breast Cancer

United States
Dana-Farber Cancer Institute

Terminated

Simvastatin in Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
Dana-Farber Cancer Institute

Terminated

Ponatinib for Squamous Cell Lung and Head and Neck Cancers

Non-Small Cell Lung Cancer, Head and Neck Cancer

United States
Dana-Farber Cancer Institute

Withdrawn

Tivozanib + Gemcitabine in Metastatic RCC

Renal Cell Carcinoma

United States
Dana-Farber Cancer Institute

Completed

Observational Study of Iron Overload in Stem Cell Transplantation

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome

United States
Duquesne University
Warner Chilcott

Completed

Effect of Assessing Risk for Osteoporosis on Physician and Patient Behaviors

Osteoporosis | Osteopenia

United States
Dana-Farber Cancer Institute

Completed

A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

Neoplasms

United States
Dana-Farber Cancer Institute

Completed

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
Dana-Farber Cancer Institute

Completed

MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients

Prostate Cancer

United States
Dana-Farber Cancer Institute

Not yet recruiting

PediCARE Health Equity Intervention in High-Risk Neuroblastoma

Neuroblastoma | Pediatric Cancer | High-risk Neuroblastoma | Financial Stress | Disparities | Poverty

United States
Dana-Farber Cancer Institute

Recruiting

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Leukemia, Myeloid | Myeloproliferative Disorders | Myeloproliferative Neoplasm

United States
Dana-Farber Cancer Institute

Recruiting

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Pancreatic Neoplasm | PDAC | PDAC - Pancreatic Ductal Adenocarcinoma

United States
Dana-Farber Cancer Institute

Recruiting

Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Multiple Myeloma | Stem Cell Transplant Complications

United States
Dana-Farber Cancer Institute

Recruiting

Investigating Hereditary Risk In Thoracic Cancers (INHERIT) (INHERIT)

Lung Cancer | Genetic Disease | Genetic Predisposition | Hereditary Diseases

United States
Dana-Farber Cancer Institute

Not yet recruiting

UNTIRE: Cancer-related Fatigue With Digital Treatment

Fatigue | Colorectal Cancer

United States
Dana-Farber Cancer Institute

Recruiting

Home Transfusion for HEME

Hematologic Malignancy

United States
Dana-Farber Cancer Institute

Recruiting

Acalabrutinib in CNSL

Refractory Central Nervous System Lymphoma | Central Nervous System Lymphoma | Recurrent Central Nervous System Lymphoma

United States
Dana-Farber Cancer Institute

Recruiting

Safe Accelerated Venetoclax Escalation in CLL (SAVE)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Dana-Farber Cancer Institute

Recruiting

Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia

Obesity | Endometrial Carcinoma | Endometrial Cancer Stage I | Endometrial Intraepithelial Neoplasia | EIN

United States
Dana-Farber Cancer Institute

Recruiting

Geriatric Thoracic Surgery Ambulation Challenge

Surgery | Thoracic Diseases | Therapy, Exercise

United States
Dana-Farber Cancer Institute

Recruiting

Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

Head and Neck Cancer

United States
Dana-Farber Cancer Institute

Recruiting

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

Lymphoproliferative Disorders | Non-Hodgkin's Lymphoma | Hodgkin's Disease | Leukemia, Lymphocytic, Chronic

United States
Dana-Farber Cancer Institute

Active, not recruiting

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

Breast Cancer

United States
Dana-Farber Cancer Institute

Completed

Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes

BK Virus Infection

United States
Dana-Farber Cancer Institute

Active, not recruiting

A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer

Cervical Cancer | Gynecologic Cancer

United States
Dana-Farber Cancer Institute

Active, not recruiting

The SPOT-HPV Study

HPV Infection | HPV Positive Oropharyngeal Squamous Cell Carcinoma

United States
Dana-Farber Cancer Institute

Active, not recruiting

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

Recurrent Head and Neck Carcinoma | Head and Neck Cancer Metastatic | Head or Neck Cancer

United States
Berner Augenklinik
medignition AG

Enrolling by invitation

Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD (SPARROW)

Wet Age-related Macular Degeneration

Switzerland
Dana-Farber Cancer Institute

Active, not recruiting

Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma

Follicular Lymphoma

United States
Dana-Farber Cancer Institute

Completed

OPTimizing Treatment Focused Genetic Testing IN Cancer (OPT-IN)

Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer

United States
Dana-Farber Cancer Institute

Active, not recruiting

The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

Pediatric Solid Tumor

United States
Dana-Farber Cancer Institute

Active, not recruiting

T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)

Breast Cancer

United States
Dana-Farber Cancer Institute

Suspended

Stereotactic Magnetic Resonance Guided Radiation Therapy

Lung Cancer | Prostate Cancer | Mesothelioma | Liver Metastases | Pancreas Cancer | Renal Cancer | Brain Metastases | Spine Metastases | Borderline Resectable Pancreatic Carcinoma | Adrenal Metastases | Oligoprogressive Nodal Metastases | Metachronous Nodal Metastases | Synchronous Nodal Metastases

United States

Clinical Trials Sponsored by Lone Forner

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations